Anti-hepatoma activity and mechanism of ursolic acid and its derivatives isolates from Aralia decaisneana

World Journal of Gastroenterology

Volumn 12, Issue 6, 2006, Pages 874-879

  Tian, Ze ^a   Lin, Geng ^a   Zheng, Rui Xia ^a   Huang, Feng ^a   Yang, Meng Su ^b   Xiao, Pei Gen ^a  

^a INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

^b CITY UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Aralia decaisneana; Hepatoma; Ursolic acid

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ARALIA DECAISNEANA EXTRACT; CYCLOOXYGENASE 2; CYCLOPHOSPHAMIDE; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 105; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PLANT EXTRACT; TERPENOID; UNCLASSIFIED DRUG; URSOLIC ACID; URSOLIC ACID 3 O BETA DEXTRO GLUCOPYRANOSYL(1-3) ALPHA LEVO ARABINOPYRANOSIDE; URSOLIC ACID 3 O BETA DEXTRO GLUCOPYRANOSYL(1-3) ALPHA LEVO ARABINOPYRANOSYL 28 O BETA DEXTRO GLUCOPYRANOSIDE; URSOLIC ACID 3 O BETA DEXTRO GLUCOPYRANOSYL(1-3) ALPHA LEVO ARABINOPYRANOSYL 28 O BETA DEXTRO GLUCOPYRANOSYL(1-6) O BETA DEXTRO GLUCOPYRANOSIDE; URSOLIC ACID 3 O[BETA DEXTRO GLUCOPYRANOSYL(1-2)][BETA DEXTRO XYLOPYRANOSYL(1-3)] ALPHA LEVO ARABINOPYRANOSYL 28 O BETA DEXTRO GLUCOPYRANOSIDE; URSOLIC ACID 3 O[BETA DEXTRO GLUCOPYRANOSYL(1-2)][BETA DEXTRO XYLOPYRANOSYL(1-3)] BETA DEXTRO XYLOPYRANOSYL 28 O BETA DEXTRO GLUCOPYRANOSIDE; URSOLIC ACID 3 O[BETA DEXTRO XYLOPYRANOSYL(1-2)][BETA DEXTRO GLUCOPYRANOSYL(1-3)] ALPHA LEVO ARABINOPYRANOSIDE; URSOLIC ACID DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARALIA; ARALIA DECAISNEANA; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL STRAIN HEPG2; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOTOXICITY; DOWN REGULATION; DRUG ISOLATION; DRUG SOLUBILITY; DRUG STRUCTURE; ENZYME DEGRADATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; LIVER CELL CULTURE; MALE; MITOSIS INHIBITION; MOUSE; NONHUMAN; RAT; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 33645090927     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i6.874     Document Type: Article

References (35)

1. Zhu ZZ, Cong WM, Liu SF, Dong H, Zhu GS, Wu MC. Homozygosity for Pro of p53 Arg72Pro as a potential risk factor for hepatocellular carcinoma in Chinese population. World J Gastroenterol 2005; 11: 289-292
2. Yuan SL, Wei YQ, Wang XJ, Xiao F, Li SF, Zhang J. Growth inhibition and apoptosis induction of tanshinone II-A on human hepatocellular carcinoma cells. World J Gastroenterol 2004; 10: 2024-2028
3. Hollosy F, Meszaros G. Bokonyi G, Idei M, Seprodi A, Szende B, Keri G. Cytostatic, cytotoxic and protein tyrosine kinase inhibitory activity of ursolic acid in A431 human tumor cells. Anticancer Res 2000; 20: 4563-4570
4. Hsu HY, Yang JJ, Lin CC. Effects of oleanolic acid and ursolic acid on inhibiting tumor growth and enhancing the recovery of hematopoietic system postirradiation in mice. Cancer Lett 1997; 111: 7-13
5. Diaz AM, Abad MJ, Fernandez L, Recuero C, Villaescusa L, Silvan AM, Bermejo P. In vitro anti-inflammatory activity of iridoids and triterpenoid compounds isolated from Phillyrea latifolia L. Biol Pharm Bull 2000; 23:1307-1313
6. Baricevic D, Sosa S, Della Loggia R, Tubaro A, Simonovska B, Krasna A, Zupancic A. Topical anti-inflammatory activity of Salvia officinalis L. leaves: the relevance of ursolic acid. J Ethnopharmacol 2001; 75: 125-132
7. Min BS, Jung HJ, Lee JS, Kim YH, Bok SH, Ma CM, Nakamura N, Hattori M, Bae K. Inhibitory effect of triterpenes from Crataegus pinatifida on HIV-I protease. Planta Med 1999; 65: 374-375
8. Raphael TJ, Kuttan G. Effect of naturally occurring triterpenoids glycyrrhizic acid, ursolic acid, oleanolic acid and nomilin on the immune system. Phytomedicine 2003; 10: 483-489
9. Banno N, Akihisa T, Tokuda H, Yasukawa K, Higashihara H, Ukiya M, Watanabe K, Kimura Y, Hasegawa J, Nishino H. Triterpene acids from the leaves of Perilla frutescens and their anti-inflammatory and antitumor-promoting effects. Biosci Biotechnol Biochem 2004; 68: 85-90
10. Tokuda H, Ohigashi H, Koshimizu K, Ito Y. Inhibitory effects of ursolic and oleanolic acid on skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate. Cancer Lett 1986; 33: 279-285
11. Subbaramaiah K, Michaluart P, Sporn MB, Dannenberg AJ. Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. Cancer Res 2000; 60: 2399-2404
12. Mizushina Y, Iida A, Ohta K, Sugawara F, Sakaguchi K. Novel triterpenoids inhibit both DNA polymerase and DNA topoisomerase. Biochem J 2000; 350 Pt 3: 757-763
13. Shishodia S, Majumdar S, Banerjee S, Aggarwal BB. Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res 2003; 63: 4375-4383
14. Liu J, Liu Y, Mao Q, Klaassen CD. The effects of 10 triterpenoid compounds on experimental liver injury in mice. Fundam Appl Toxicol 1994; 22: 34-40
15. Saraswat B, Visen PK, Agarwal DP. Ursolic acid isolated from Eucalyptus tereticomis protects against ethanol toxicity in isolated rat hepatocytes. Phytother Res 2000; 14: 163-166
16. Ovesna Z, Vachalkova A, Horvathova K, Tothova D. Pentacyclic triterpenoic acids: new chemoprotective compounds. Minireview. Neoplasma 2004; 51: 327-333
17. Tian Z, Yang M, Huang F, Li K, Si J, Shi L, Chen S, Xiao P. Cytotoxicity of three cycloartane triterpenoids from Cimicifuga dahurica. Cancer Lett 2005; 226: 65-75
18. Miyase T, Shiokawa KI, Zhang DM, Ueno A. Araliasaponins I-XI, triterpene saponins from the roots of Aralia decaisneana. Phytochemistry 1996; 41: 1411-1418
19. Sambrook J, Fritsch E F, Maniatis T, In Molecular cloning, A Laboratory Manual, 2nd ED.; Cold Spring Harbor Laboratory press: New York, 1989
20. Chen WF, Huang MH, Tzang CH, Yang M, Wong MS. Inhibitory actions of genistein in human breast cancer (MCF-7) cells. Biochim Biophys Acta 2003; 1638: 187-196
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408
22. Setzer WN, Setzer MC. Plant-derived triterpenoids as potential antineoplastic agents. Mini Rev Med Chem 2003; 3: 540-556
23. Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 1991; 266: 12866-12872
24. Jones DA, Carlton DP, McIntyre T M, Zimmerman GA, Prescott SM. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J Biol Chem 1993; 268: 9049-9054
25. DuBois RN, Awad J, Morrow J, Roberts LJ 2nd, Bishop PR. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester. J Clin Invest 1994; 93: 493-498
26. Eberhart CE, Coffey R J, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994; 107: 1183-1188
27. Tucker ON, Dannenberg AJ, Yang EK, Zhang F, Teng L, Daly JM, Soslow RA, Masferrer JL, Woerner BM, Koki AT, Fahey TJ 3rd. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res 1999; 59: 987-990
28. Buecher B, Broquet A, Bouancheau D, Heymann MF, Jany A, Denis MG, Bonnet C, Galmiche JP, Blottiere HM. Molecular mechanisms involved in the antiproliferative effect of two COX-2 inhibitors, nimesulide and NS-398, on colorectal cancer cell lines. Dig Liver Dis 2003; 35: 557-565
29. Detjen KM, Welzel M, Wiedenmann B, Rosewicz S. Nonsteroidal anti-inflammatory drugs inhibit growth of human neuroendocrine tumor cells via G1 cell-cycle arrest. Int J Cancer 2003; 107: 844-853
30. Narayanan BA, Condon MS, Bosland MC, Narayanan NK, Reddy BS. Suppression of N-methyl-N-nitrosourea/testosterone-induced rat prostate cancer growth by celecoxib: effects on cyclooxygenase-2, cell cycle regulation, and apoptosis mechanism(s). Clin Cancer Res 2003; 9: 3503-3513
31. Kim DK, Baek JH, Kang CM, Yoo MA, Sung JW, Chung HY, Kim ND, Choi YH, Lee SH, Kim KW. Apoptotic activity of ursolic acid may correlate with the inhibition of initiation of DNA replication. Int J Cancer 2000; 87: 629-636
32. Yamagishi N, Saito Y, Ishihara K, Hatayama T. Enhancement of oxidative stress-induced apoptosis by Hsp105alpha in mouse embryonal F9 cells. Eur J Biochem 2002; 269: 4143-4151
33. Yamagishi N, Ishihara K, Saito Y, Hatayama T. Hsp105alpha enhances stress-induced apoptosis but not necrosis in mouse embryonal f9 cells. J Biochem 2002; 132: 271-278
34. Castelli C, Rivoltini L, Rini F, Belli F, Testori A, Maio M, Mazzaferro V, Coppa J, Srivastava PK, Parmiani G. Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer. Cancer Immunol Immunother 2004; 53: 227-233
35. Wadhwa R, Sugihara T, Yoshida A, Nomura H, Reddel RR, Simpson R, Maruta H, Kaul SC. Selective toxicity of MKT-077 to cancer cells is mediated by its binding to the hsp70 family protein mot-2 and reactivation of p53 function. Cancer Res 2000; 60: 6818-6821